120 related articles for article (PubMed ID: 9778616)
1. Residual disease and presence of human papillomavirus after conization.
Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Itamochi H; Cheng X; Terakawa N
Oncology; 1998; 55(6):517-20. PubMed ID: 9778616
[TBL] [Abstract][Full Text] [Related]
2. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang KG; Huang HJ; Chao A
Am J Obstet Gynecol; 2001 Apr; 184(5):940-5. PubMed ID: 11303202
[TBL] [Abstract][Full Text] [Related]
3. Negative predictive value of human papillomavirus test following conization of the cervix uteri.
Jain S; Tseng CJ; Horng SG; Soong YK; Pao CC
Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982
[TBL] [Abstract][Full Text] [Related]
4. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
5. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
6. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
7. Margin clearance and HPV infection do not influence the cure rates of early neoplasia of the uterine cervix by laser conization.
Izumi T; Kyushima N; Genda T; Kobayashi N; Kanai T; Wakita K; Kuramoto H
Eur J Gynaecol Oncol; 2000; 21(3):251-4. PubMed ID: 10949387
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infection in patients with residual or recurrent cervical intraepithelial neoplasia.
Takac I
Tumori; 2008; 94(1):83-6. PubMed ID: 18468341
[TBL] [Abstract][Full Text] [Related]
9. Detection of human papillomaviruses in cancer of the uterine cervix.
Molendijk LW
S Afr Med J; 1996 Apr; 86(4):379, 381. PubMed ID: 8693384
[No Abstract] [Full Text] [Related]
10. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
11. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Obstet Gynecol; 2009 Jul; 114(1):87-92. PubMed ID: 19546763
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
15. Management of carcinoma in situ of the cervix.
Sprang ML; Isaacs JH; Boraca CT
Am J Obstet Gynecol; 1977 Sep; 129(1):47-50. PubMed ID: 900168
[TBL] [Abstract][Full Text] [Related]
16. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
17. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
19. [HPV 16 DNA occurrence in lymph nodes of patients with cervical carcinoma].
Łukaszuk K; Liss J; Gulczyński J; Woźniak I; Emerich J; Wójcikowski C
Ginekol Pol; 2003 Feb; 74(2):87-90. PubMed ID: 12715415
[TBL] [Abstract][Full Text] [Related]
20. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
